Agenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures

Similar documents
Pain Management in Patients on Buprenorphine Maintenance

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Special Populations health complications of Substance Use Anthony Dekker DO, OMED 2018 San Diego

MAT for Opioid Dependence. MAT and Pain Management. Epidemiology. Epidemiology. Factors Impacting Pain Perception 9/23/2014

Pain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD

Opioids Research to Practice

Cancer Pain: A Clinical Overview. Linda A. King, MD Section of Palliative Care and Medical Ethics

Learning Objectives. Perioperative goals. Acute Pain in the Chronic Pain Patient for Ambulatory Surgery 9/8/16

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Acute pain management in opioid tolerant patients. Muhammad Laklouk

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Practical Management Of Osteoporosis

John Murphy DO, MS Lynx Healthcare

TACKLING THE OPIOID EPIDEMIC: THE DENTAL TEAM'S RESPONSIBILITY ACUTE PAIN MANAGEMENT

OBSERVATION SHEET TOPIC CLINICAL SCENARIO. OBSERVATIONS MADE (Use the skills objectives/ provider tasks to evaluate the conversation)

6/27/2017. Disclosures. Overview. Case Overview

Substitution Therapy for Opioid Use Disorder The Role of Suboxone

Organizing your Practice for Efficient Pain Assessment. Session #4 Roman D. Jovey, MD

Comedy of Errors: Methadone and Buprenorphine

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Opioids Research to Practice

Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder

Pain Management: Overview of A Practical Approach

GOALS AND OBJECTIVES

OBSERVATION SHEET TOPIC CLINICAL SCENARIO. OBSERVATIONS MADE (Use the skills objectives/ provider tasks to evaluate the conversation)

Cases of Patients with OUD. Objectives

Opioids Research to Practice

Introduction. Introduction. Demonstration of an Effective Post-Op Pain Management Protocol In Distal Radius Fractures

Medication-assisted opioid addiction treatments: OB/GYN

Objectives: What is your Definition of Pain? 8/16/2017

Intractable pain syndrome is defined as persistent pain despite all the reasonable efforts to treat.

Overview of Essentials of Pain Management. Updated 11/2016

Medications for the Treatment of Neuropathic Pain

Safe and Competent Opioid Prescribing

Recognizing Narcotic Abuse and Addiction and Helping Those With It

Disclosures. Ms. Walsh has nothing to disclose Ms. Broglio is on the speaker s bureau for Genentech and Meda Pharmaceuticals

Presentation objectives. Overcoming Acute Pain Management Hurdles in the Tertiary Setting The High Risk Patient

Opioids Research to Practice

Neck Pain. Frank Thomas BSc(Hons) MBChB FANZCA FFPMANZCA

Fighting the Good Fight: How to Convert Opioids Just Right!

PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose

Pain Management in Hospice and Palliative Care

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

Subject: Pain Management (Page 1 of 7)

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS

Opioid Review and MAT Clinic CDC Guidelines

Clinical and Contextual Evidence Reviews

Chronic Pain Pharmacist role in the clinic

POLICY DOCUMENT. CG/pain management in opioid dependency/03/15. Associate Director of Pharmacy

STARTING SUBOXONE IN PRIMARY CARE

Disclosures. The Problem. The Problem. The Problem. The Problem. Buprenorphine Use in Combined Chronic Pain and Opioid Addiction

WORRIED ABOUT PAIN AFTER ORAL SURGERY?

Pain and the MGH Promise

BJF Acute Pain Team Formulary Group

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

MAT IN PREGNANCY KAYLA LIFE STAGE 1: ADOLESCENCE LIFE STAGE 2: EARLY ADULTHOOD. family History of addiction. addiction to oral opioids

OBSERVATION SHEET TOPIC CLINICAL SCENARIO. OBSERVATIONS MADE (Use the skills objectives/ provider tasks to evaluate the conversation)

ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Dr Alistair Dunn. General Practitioner Northland District Health Board Whangarei

Disclosures. Management of Chronic Pain for Cancer Survivors. University of Kentucky HealthCare, Lexington, KY

Medication Assisted Treatment

Palliative Prescribing - Pain

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

Jennifer Wyman, MD, Academic Lead, Opioids Clinical Primer Assistant Professor, Dept. of Family & Community Medicine, University of Toronto

Acute Pain NETP: SEPTEMBER 2013 COHORT

Disclosures. Management of Chronic, Non- Terminal Pain. Learning Objectives. Outline. Drug Schedules. Applicable State Laws

Associate Professor Supranee Niruthisard Department of Anesthesiology Faculty of Medicine Chulalongkorn University January 21, 2008

New Guidelines for Prescribing Opioids for Chronic Pain

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?

Opioid Dependence and Buprenorphine Management

Update on Pain: Collaborative Care for the Complex Patient

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

Treatment Alternatives for Substance Use Disorders

44th Annual CME Conference for Physician Assistants. Alexander Bautista, MD Assistant Professor Anesthesiology and Pain Medicine

Inpatient Management of Trauma Related Pain

Methadone and Naltrexone ER

Neuropathic pain (pain due to nerve damage)

Intraspinal (Neuraxial) Analgesia Community Nurses Competency Test

OAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM

Michael O Neil, Pharm.D. Professor and Vice-Chair, Department of Pharmacy Practice Drug Diversion, Substance Abuse, and Pain Management Consultant

Prescription Drug Monitor Programs (PMDP): Combating prescription drug misuse and abuse. A physician s perspective.

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Pain Management. University of Illinois at Chicago College of Nursing

Rule Governing the Prescribing of Opioids for Pain

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Pain management in palliative care. Dr. Stepanie Lippett and Sister Karen Davies-Linihan

Dr. Clark s Frequently Asked Questions

Test User got 22 of 22 possible points on the Risk Reduction Strategies for ER/LA Opioids Post-Test. Total score: 100 %

Pain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM

Source: National Vital Statistics

BASICS OF OPIOID PRESCRIBING 10:30-11:45AM

9/30/2017. Case Study: Complete Pain Assessment and Multimodal Approach to Pain Management. Program Objectives. Impact of Poorly Managed Pain

Striking a Balance: a provider perspective.

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

Transcription:

Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT Case Discussions August 26, 2014 PCSS MAT Webinar Sponsored by the American Psychiatric Association Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research Education Unit Boston University School of Medicine & Boston Medical Center Daniel Alford, MD Disclosures I have nothing to disclose with regards to commercial support. Agenda Methadone Case 1: MMT acute pain management Case 2: MMT chronic pain management Buprenorphine Case 3: BMT perioperative pain management Case 4: BMT acute pain management Case 5: BMT chronic pain management Naltrexone Case 6: NMT acute pain management 1

MMT Acute Pain Case 1: MMT acute pain management You are called by an orthopedic surgeon colleague for advice on pain management for the following patient 55 y.o. male with h/o opioid use disorder on MMT, wellcontrolled hypertension tobacco use (1 ppd) is s/p motor vehicle crash with a pelvic femur fracture. He is currently in the operating room having an internal fixation of his femur He has a 38 year history of opioid (heroin) dependence has been maintained on methadone 120 mg per day with weekly group counseling for the past 10 years. He has been on maximum take home doses for the past 8 years Case 1: MMT acute pain management What would you recommend regarding this patient s methadone peri operatively? this patient s acute pain peri operatively? 2

Case 1: MMT acute pain management Take Home Points Communicate with the MMT program On admission verify dose On discharge, last dose any meds that may show up in drug testing MMT will not treat acute pain Manage opioid debt po or parenteral dosing Opioid analgesics in addition to MMT will not increase CNS or respiratory depression or compromise patient s recovery Increased pain sensitivity may necessitate higher doses at shorter intervals Scheduled dosing or PCA vs prn during the severe acute pain MMT Chronic Pain Case 2: MMT chronic pain management 42 yo male with type 2 DM (insulin requiring) with painful diabetic neuropathy, diabetic nephropathy (GFR 40 = CKD stage 3B), hepatitis C on MMT 90 mg per day for the past 5 years Neuropathic pain treated with gabapentin 800 mg tid, acetaminophen 500 mg tid, amitriptyline 25 mg qhs acupuncture Has been tried, without benefit, capsaicin, NSAIDs (now limited by CKD), tramadol, duloxetine, venlafaxine cognitive behavioral therapy Pain remains very severe (7 9/10) including allodynia is disabling Exam c/w diabetic neuropathy, normal vascular exam, no skin lesions He is requesting a 10 mg increase in his methadone dose to 100 mg from his MMT program to better control his chronic pain 3

Case 2: MMT chronic pain management Would you recommend an increase his methadone dose, why or why not? Would you consider adding an opioid analgesic to his pain regimen? If so, how? Case 2: MMT chronic pain management Take Home Points 1 Analgesia from methadone lasts 6 8 hours Methadone dosed qd may be a good test for opioid responsiveness Do you get any pain relief from your morning methadone dose yes, all day but not enough (pain likely withdrawal mediated pain) yes, but it only lasts 8 hours (pain may be opioid responsive) no, not at all (pain may be opioid resistant) Case 2: MMT chronic pain management Take Home Points 2 For patients on MMT Closely monitored e.g., drug testing, pill counts Methadone will block euphoric effects of opioid analgesics Prescribed opioid analgesics may interference with drug testing e.g., opiates semisynthetics Risk of diversion Most MMT programs only able to dose QD (some clinics will dispense split doses ) 4

BMT Perioperative Pain Case 3: BMT perioperative pain management You are called by an orthopedic surgeon colleague for advice on pain management for the following patient 65 y.o. female with h/o opioid use disorder, asthma right hip avascular necrosis due to long term corticosteroid use is being scheduled for an elective total hip replacement Maintained on buprenorphine 16 mg SL per day for treatment of her opioid use disorder for the past 2 years Chronic pain has been managed with a combination of maximum dose naproxen acetaminophen but pain has recently become more severe is limiting her ability to continue working as a bank manager Case 3: BMT perioperative pain management The surgeon remembers hearing at a national conference that the buprenorphine should be stopped 5 days prior to the surgery. Do you agree with this recommendation? If so, why? If not, why not? What would you recommend regarding buprenorphine pain management in this patient scheduled for elective surgery? 5

Case 3: BMT perioperative pain management Take Home Points Stopping buprenorphine 5 days preop, while makes sense if you are concerned about opioid blockade, is likely destabilizing the patient s recovery preoperatively is likely not necessary Options If you believe the observational data that is accumulating mostly from observational studies, then continuing buprenorphine perioperatively will not prevent postoperative opioid analgesic efficacy (Kornfeld H 2010, Jones HE et al. 2009, Oifa S et al. 2009, Meyer M et al. 2010, Macintyre PE et al.2013) If you are worried about opioid blockade, stop buprenorphine on the day of surgery treat both the perioperative pain opioid debt with combination of ER/LA opioids IR/SA opioids BMT Acute Pain Case 4: BMT acute pain management You are called by an ED colleague for advice on treating acute pain in your patient 32 y.o. male with severe, 10/10, right shoulder pain after an acute dislocation rotator cuff tear while playing flag football His shoulder will be reduced stabilized in the ED with orthopedic follow up in 5 days Has a 10 year history of prescription opioid addiction Has been maintained on buprenorphine 16 mg SL per day for the past 2 years Engaged in weekly group counseling, goes to NA meetings 2 3 times per week has had no relapses since starting office based treatment He works full time as a mechanic at a VW dealership 6

Case 4: BMT acute pain management What would you recommend for pain management in the ED? What would you recommend for pain management upon discharge from the ED? Case 4: BMT acute pain management Take Home Points There are options Divide buprenorphine to every 6 8 hours for analgesic properties add non opioids or IR/SA opioids or dual mechanism opioids (e.g. tramadol) if you believe the animal studies showing opioid efficacy in spite of buprenorphine maintenance (Kogel B, et al. 2005, Englberger W et al. 2006) Use supplemental doses of buprenorphine if you believe the data suggesting that there may not be an analgesic ceiling effect (Dahan A et al. 2006) BMT Chronic Pain 7

Case 5: BMT chronic pain management 42 yo female with chronic LBP after a bicycling accident 8 years ago has been referred to you for BMT for her oxycodone addiction. She is s/p 2 failed back surgeries, numerous steroid injections, nerve blocks, currently has a spinal cord stimulator Pain is constant 7 10/10 radiates down both legs. It is worse when she is sitting walking best when she is lying down She is married, with 2 children is unemployed on disability Exam, no numbness or weakness or point tenderness Back pain is being treated with ER/LA oxycodone 40 mg bid with IR/SA oxycodone 10 mg q8 for breakthrough pain Has had numerous aberrant medication taking behaviors including escalating her dose running out early on numerous occasions She is also on ibuprofen 800 mg with acetaminophen 500 mg tid The patient does not think she is addicted but just in terrible pain Case 5: BMT chronic pain management If you think she has an opioid use disorder chronic pain, would you start her on buprenorphine maintenance? If so, how would you dose the buprenorphine? Case 5: BMT chronic pain management Take Home Points Systematic review of 10 studies all studies (low quality) reported effectiveness in treating chronic pain (Cotes J, Montgomery L. 2014) Buprenorphine can be prescribed in office based practice for both opioid dependence (requires X number, likely covered) chronic pain management (offlabel, no X number required, likely not covered) For pain, buprenorphine will need to be dosed every 8 hours Use same universal precautions that you would use with any prescription opioid for chronic pain including a patient provider agreement with informed consent, drug testing, pill counts, use of the Prescription Drug Monitoring Program (Gourlay DL et al. 2005) 8

NMT Acute Pain Case 6: NMT acute pain management You are called by an ED colleague for advice on treating acute pain in the following patient 25 y.o. female presents with acute right sided flank pain due to large renal/ureteral stones She is maintained on IM depot naltrexone 380 mg every 4 weeks for treatment of her opioid dependence Her last naltrexone injection was 7 days ago Case 6: NMT acute pain management What would you recommend for pain management? 9

Case 6: NMT acute pain management Take Home Points IM depot naltrexone peak plasma within 2 3 days, decline begins in 14 days For acute pain consult anesthesia either try to use nonopioids or interventional strategies If opioids are required overriding naltrexone blockade, in animal models, was achieved at 6 20x usual dose without significant respiratory depression or sedation (Dean RL et al. 2008) should be done in monitored setting Delay elective surgery for at least 30 days from last injection 10